Eli Lilly's stock surges toward a 5th straight record after an earnings beat and upbeat outlook

Shares of Eli Lilly and Co. LLY, +5.77% rallied toward a fifth-straight record close in premarket trading Tuesday, after the drug maker’s fourth-quarter earnings beat expectations, helped by a 16% jump in prices, and provided an upbeat 2024 revenue outlook. Net income rose to $2.19 billion, or $2.42 a share, from $1.94 billion, or $2.14 a share, in the year-ago period. Excluding nonrecurring items, adjusted earnings per share of $2.49 beat the FactSet consensus of $2.30. Revenue jumped 28.1% to $9.35 billi ...